drugset / Trial / NCT04134442

Improving Pain Management After Total Shoulder Replacement Using Bupivacaine Liposome

NCT04134442 ↗

RandomizedParallel-groupDouble-blindPrevention

Summary

To improve pain control and decrease opioid requirements for subjects undergoing Total Shoulder Replacement.

Timeline

Start
2019-12-09
Primary completion
2021-09-23
Completion
2021-09-23

Outcome

Outcome not reported

Stopped: “A new large meta-analysis was published. The results showed the likelihood that liposomal bupivacaine and nerve blocks no longer offer significant contribution. Decision was made to terminate the study.”

Drugs

EvaluationDrugModalityDoseRoute
Subject Bupivacaine Other / unclassified 10 ml Other

Indications